Showing results (1071-1080 of 1,161) with videos related to

Sort By:
Pageof 117
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancerPaolo Nuciforo, John Townend, Martine J Piccart, et al.
Nature Medicine|April 4, 2017
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel diseaseNathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, et al.
Bone Marrow Transplantation|December 4, 2025
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWPAli Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle, et al.
Nature|January 5, 2000
T-cell co-stimulation through B7RP-1 and ICOSS K Yoshinaga, J S Whoriskey, S D Khare, et al.
Lancet (London, England)|January 20, 2012
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trialJosé Baselga, Ian Bradbury, Holger Eidtmann, et al.
JAMA Oncology|December 15, 2022
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk GroupsStefan Timmerman, Lil Valentin, Jolien Ceusters, et al.
Pediatric Nephrology (Berlin, Germany)|November 11, 2024
Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndromeAlicia Fayad, Iliana Principi, Alejandro Balestracci, et al.
Pediatric Blood & Cancer|March 21, 2006
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study GroupDaniel M Green, Cecilia A Cotton, Marcio Malogolowkin, et al.
Pediatric Blood & Cancer|June 1, 2007
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study GroupMarcio Malogolowkin, Cecilia A Cotton, Daniel M Green, et al.
Pediatric Nephrology (Berlin, Germany)|July 2, 2018
Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndromeLaura F Alconcher, Paula A Coccia, Angela Del C Suarez, et al.
Pageof 117